Rice
bakaenii disease (RBD) is a widespread and devastating disease
mainly caused by Fusarium fujikuroi. Pydiflumetofen
(Pyd) is a novel succinate dehydrogenase inhibitor (SDHI) with strong
inhibitory activity against F. fujikuroi, but the
mechanism of resistance to Pyd has not been well studied for this
pathogen. Through fungicide adaption, a total of 12 Pyd-resistant
mutants were obtained and the resistance level could be divided into
three categories of high resistance (HR), moderate resistance (MR),
and low resistance (LR) with resistance factors (RF) of 184.04–672.90,
12.63–42.49, and <10, respectively. Seven genotypes of point
mutations in FfSdh genes (FfSdhBH248L,
FfSdhBH248D, FfSdhBH248Y, FfSdhC2
A83V, FfSdhC2
H144Y, FfSdhDS106F, and FfSdhDE166K) were found in these mutants, among
which genotype FfSdhBH248L and FfSdhC2
A83V mutants showed HR, genotype FfSdhBH248D, FfSdhBH248Y, FfSdhC2
H144Y, and FfSdhDE166K mutants
showed MR, and genotype FfSdhDS106F mutants showed LR.
Moreover, all the substitutions of amino acid point mutations including
FfSdhBH248L/D/Y, FfSdhC2
A83V,H144Y, and FfSdhDS106F,E166K conferring resistance to Pyd in F. fujikuroi were verified by protoplast transformation.
Additionally, a positive cross-resistance was detected between Pyd
and another SDHI fungicide penflufen, while no cross-resistance was
detected between Pyd and phenamacril, prochloraz, azoxystrobin, carbendazim,
or fludioxonil. Although pathogenicity of the mutants was increased
compared with that of the wild-type parental strains, the mycelial
growth rate and spore production levels of the resistant mutants were
significantly decreased (P < 0.05), indicating
significant fitness cost of resistance to Pyd in F. fujikuroi. Taken together, the risk of resistance to Pyd in F. fujikuroi might be moderate, and appropriate precautions against resistance
development in natural populations should be taken into account when
Pyd is used for the control of RBD.